Publications.
Eckstein Y, Kessler B, Hinrichs A, Novak I, von Thaden A, Lorenzen T, Rathkolb B, Scholz A, Blutke A, Koopmans SJ, Hrabĕ de Angelis M, Christoffersen BØ, Wolf E, Renner S. Protocol for in vivo assessment of glucose control and insulin secretion and sensitivity in the pig. STAR Protocols. April 2025;6.
Ambre Baillou, Gaël Auray, Francisco Brito, Marius Botos, Alizée Huber, Artur Summerfield, Stephanie C. Talker Unraveling porcine dendritic-cell diversity: welcome tDC and DC3. Frontiers in Immunology. Volume 16 – 2025
Conghui Li, Wei Lv, Zhiwei He, Xiaoguang Pan, Yuchen Zeng, Jan Mulder, Evelina Sjöstedt, Zhiwei Huang, Wei Liu, Liangzhi Xu, Eli Eisenberg, Lin Lin, Jacob B Hansen, Jinrong Huang, Yonglun Luo Landscape of A-I RNA editing in mouse, pig, macaque, and human brains Nucleic Acids Research, Volume 53, Issue 11, 24 June 2025, gkaf534
Aisha Shigna Nadukkandy, Sowmiya Kalaiselvan, Lin Lin, Yonglun Luo Clinical application of single-cell RNA sequencing in disease and therapy Clin Transl Med. 2025;15:e70512.
Alessia Cavazza, Francisco J. Molina-Estévez, Álvaro Plaza Reyes, Victor Ronco, Asma Naseem, Špela Malenšek, Peter Pečan, Annalisa Santini, Paula Heredia, Araceli Aguilar-González, Houria Boulaiz, Qianqian Ni, Marina Cortijo-Gutierrez, Kristina Pavlovic, Inmaculada Herrera, Berta de la Cerda, Emilio M. Garcia-Tenorio, Eva Richard, Sergio Granados-Principal, Arístides López-Márquez, Mariana Köber, Marijana Stojanovic, Melita Vidaković, Irene Santos-Garcia, Lorea Blázquez, Emily Haughton, Dongnan Yan, Rosario María Sánchez-Martín, Loubna Mazini, Gloria Gonzalez Aseguinolaza, Annarita Miccio, Paula Rio, Lourdes R. Desviat, Manuel A.F.V. Gonçalves, Ling Peng, Cecilia Jiménez-Mallebrera, Francisco Martin Molina, Dhanu Gupta, Duško Lainšček, Yonglun Luo, Karim BenabdellahAdvanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group Molecular Therapy Nucleic Acids, 2025; 36
Funding acknowledgement
This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101165643. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe and Breakthrough T1D and VeriSIM Life.
Funding acknowledgement
This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101165643. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe and Breakthrough T1D and VeriSIM Life.